Maze Therapeutics Inc

MAZE USD0.001
Create an alert
Sell$28.09
Buy$29.60
$0.12 (0.00%)
Last updated today at 07:13 UTC

Key metrics

Open-
Previous close$28.53
Market cap$1.54bn
P/E ratio-
Volume480,730
Dividend yield0.00%
EMS-

Maze Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in harnessing the power of human genetics and variant functionalization with its Maze Compass platform to develop ...

  • LocationUnited States
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencyUSD
  • Shares in issue55.35m

Take a closer look at this company’s financial statements and dividend information.

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.